PCOS in India: Why It's So Common and What to Do About It

India has the highest prevalence of polycystic ovary syndrome (PCOS) in the world. Estimates place the proportion of Indian women of reproductive age affected by PCOS at 20 to 25% — compared to 10 to 13% globally. Walk into any gynaecology clinic in Pune and PCOS will be among the most common diagnoses discussed. It is the leading cause of ovulatory infertility, one of the most common hormonal disorders in Indian women, and a condition whose long-term metabolic consequences are still insufficiently appreciated by patients and healthcare providers alike.

And yet, despite its prevalence, PCOS is frequently misunderstood, over-diagnosed, under-diagnosed, and undertreated. Many women receive a PCOS diagnosis without a clear explanation of what it means, what causes it, or what they should actually do about it. This guide addresses all of those gaps.

What Is PCOS?

Polycystic ovary syndrome is an endocrine and metabolic disorder characterised by a combination of features: irregular or absent ovulation, elevated androgens (male hormones), and a characteristic appearance of the ovaries on ultrasound. It is a syndrome — a cluster of features — rather than a single disease with one defined mechanism. This is why the clinical picture varies significantly between individuals.

The name is somewhat misleading. "Polycystic" does not mean the ovaries are filled with cysts. It refers to the presence of multiple small follicles — each containing an immature egg — that appear as a string-of-pearls pattern on ultrasound. These follicles fail to develop to maturity and release an egg each cycle, which is why irregular ovulation is the central fertility problem in PCOS.

Why Is PCOS So Common in India?

Several factors contribute to the exceptionally high PCOS prevalence among Indian women:

Genetic Predisposition

PCOS has a strong genetic component — it runs in families, and Indian women appear to carry a higher genetic susceptibility than many other ethnic groups. First-degree relatives of women with PCOS have significantly elevated rates of the condition.

Insulin Resistance

Insulin resistance — where the body's cells do not respond normally to insulin — is present in 70 to 80% of overweight Indian women with PCOS and in approximately 20 to 30% of lean Indian women with the condition. Indians as a population tend to develop insulin resistance at lower BMIs than Western populations — partly due to higher rates of central adiposity (fat stored around the abdomen and organs) for a given body weight. This metabolic vulnerability amplifies PCOS expression.

Dietary and Lifestyle Patterns

A diet dominated by refined carbohydrates — white rice, white bread, processed foods, sweet beverages — drives insulin spikes and perpetuates insulin resistance. Combined with increasingly sedentary lifestyles, this creates a metabolic environment that strongly promotes PCOS expression in genetically susceptible women.

Stress and Cortisol

Chronic psychological stress elevates cortisol, which drives androgen production from the adrenal glands and worsens insulin resistance. Urban Indian women navigating professional, familial, and social pressures face significant chronic stress loads that may contribute to PCOS expression.

What Are the Symptoms of PCOS?

PCOS presents differently in different women. No two cases are identical. The most common features include:

• Irregular periods: Cycles longer than 35 days, fewer than 8 periods per year, or absent periods entirely. This is caused by failure to ovulate regularly.
• Signs of elevated androgens: Acne (particularly along the jawline, chin, and chest), excessive facial and body hair (hirsutism), thinning of scalp hair (androgenic alopecia), and darkening of the skin in folds (acanthosis nigricans — a sign of insulin resistance).
• Polycystic ovarian morphology: More than 20 follicles per ovary on ultrasound, or total ovarian volume above 10 ml.
• Weight concerns: Many women with PCOS find it harder to maintain a healthy weight — not simply because of caloric intake, but because insulin resistance promotes fat storage, particularly in the abdomen.
• Fertility challenges: Irregular ovulation reduces the number of fertile windows per year, and the quality of ovulation in PCOS may be reduced even when it does occur.
• Mood changes: Anxiety and low mood are significantly more common in women with PCOS, driven by hormonal imbalance, body image concerns, and the emotional weight of a chronic condition.

The Three PCOS Phenotypes

The Rotterdam criteria (2003) allow diagnosis of PCOS when any two of three features are present: oligoanovulation, biochemical or clinical hyperandrogenism, and polycystic ovarian morphology on ultrasound. This creates four recognised phenotypes:

• Phenotype A (Classic): Anovulation + hyperandrogenism + polycystic ovaries — the most common and most metabolically severe form
• Phenotype B: Anovulation + hyperandrogenism without polycystic ovaries
• Phenotype C: Hyperandrogenism + polycystic ovaries with regular ovulation
• Phenotype D (Lean PCOS): Anovulation + polycystic ovaries without clinical hyperandrogenism — the mildest metabolic profile

The phenotype affects both the severity of symptoms and the long-term metabolic risk — and should influence treatment decisions.

Diagnosing PCOS: What Tests Are Needed?

A correct PCOS diagnosis requires more than a single ultrasound. The Rotterdam criteria require exclusion of other conditions that can mimic PCOS before the diagnosis is confirmed. The diagnostic workup includes:

• Menstrual history and clinical assessment of androgenic features
• Day 2 to 3 hormonal panel: FSH, LH, oestradiol, total testosterone, DHEAS, prolactin, TSH — to exclude other causes of irregular cycles
• 17-hydroxyprogesterone: To exclude congenital adrenal hyperplasia, which can present identically to PCOS
• Fasting glucose and insulin (HOMA-IR): To quantify insulin resistance
• AMH: Often elevated in PCOS — supports diagnosis
• Transvaginal ultrasound: Follicle count, ovarian volume, endometrial thickness
• Lipid profile: LDL, HDL, triglycerides — PCOS is associated with dyslipidaemia

Treatment: What Works and for Whom

Lifestyle Modification

For overweight women with PCOS, lifestyle intervention is first-line treatment — not just general health advice, but specific, evidence-based fertility and hormonal treatment. Weight loss of just 5 to 10% has been shown to restore ovulation in approximately 55 to 60% of women with PCOS who are overweight. The mechanism is straightforward: reducing central adiposity reduces insulin resistance, which reduces androgen production, which allows the hormonal cascade driving ovulation to normalise.

Ovulation Induction for Fertility

For women with PCOS who want to conceive, letrozole (an aromatase inhibitor) is the current first-line medication for ovulation induction — more effective than the older clomiphene citrate and associated with lower multiple pregnancy rates. Monitoring with ultrasound is important to confirm response and prevent ovarian hyperstimulation. IUI may be combined with ovulation induction to improve per-cycle conception probability.

Hormonal Management for Cycle Regulation

For women who are not trying to conceive, combined oral contraceptive pills suppress androgen production, regulate cycles, protect the endometrium from unopposed oestrogen exposure, and improve acne and hirsutism. They are the standard first-line treatment for cycle regulation and androgen management in PCOS.

Metformin

Metformin is an insulin-sensitising medication widely used in PCOS management. It reduces hepatic glucose production, improves cellular insulin sensitivity, and — particularly in combination with lifestyle changes — can restore ovulation, reduce androgen levels, and support weight management. It is also used periconceptionally in PCOS to reduce the risk of early pregnancy loss and gestational diabetes.

Inositols

Myo-inositol and D-chiro-inositol act as natural insulin sensitisers. Evidence from multiple small studies supports their use in PCOS — improving ovulation frequency, reducing androgen levels, and improving egg quality in IVF cycles. They are generally safe, well-tolerated, and a reasonable adjunct to lifestyle and medical management.

IVF for PCOS

IVF is appropriate for PCOS patients when ovulation induction and IUI have failed after an adequate number of cycles, when other fertility factors are present (tubal damage, male factor), or when the woman is older and needs a more efficient route to pregnancy. Women with PCOS undergoing IVF require careful management: their ovaries respond vigorously to stimulation, creating a significant risk of ovarian hyperstimulation syndrome (OHSS). Modern antagonist protocols with a GnRH agonist trigger and freeze-all strategy have substantially reduced OHSS risk.

PCOS and Long-Term Health

PCOS is not just a reproductive condition — it is a lifelong metabolic disorder with significant long-term health implications. Untreated insulin resistance in PCOS leads to a 5 to 10-fold increased risk of type 2 diabetes, significantly elevated cardiovascular risk, and higher rates of non-alcoholic fatty liver disease. Women with PCOS also face elevated risk of endometrial hyperplasia and endometrial cancer from chronic anovulation and unopposed oestrogen exposure. Long-term management — well beyond the reproductive years — is essential.

Frequently Asked Questions

Q1. Does PCOS go away after pregnancy?

PCOS is a lifelong condition. Pregnancy may temporarily suppress some symptoms — the hormonal environment of pregnancy naturally suppresses the hyperandrogenic state — but PCOS does not resolve permanently after delivery. Symptoms typically return in the postpartum period, particularly as the menstrual cycle resumes. Long-term management remains relevant.

Q2. Is PCOS hereditary?

Yes — PCOS has a strong genetic component. First-degree relatives (sisters and daughters) of women with PCOS have significantly elevated rates of the condition. Sons of women with PCOS have elevated rates of metabolic syndrome and insulin resistance. If your mother or sister has PCOS, your own risk is elevated — making baseline screening worthwhile even if you are currently asymptomatic.

Q3. Can thin women have PCOS?

Yes. Lean PCOS — PCOS in women of normal or low body weight — accounts for approximately 20 to 30% of all PCOS cases. Lean PCOS often presents with a less severe metabolic profile but can still cause significant hormonal disruption, irregular periods, infertility, and androgenic symptoms. See our dedicated article on lean PCOS for a full discussion.

Q4. Is the PCOS I have now the same as what I'll have in 20 years?

PCOS changes over time. Androgens tend to decline with age, so hirsutism and acne may improve in the mid-to-late thirties. However, the metabolic consequences — insulin resistance, risk of diabetes, cardiovascular risk — tend to worsen if not actively managed. The condition evolves; so does the management focus at different life stages.

Q5. If I take the pill for PCOS, does it treat the underlying condition?

No. The combined oral contraceptive pill manages symptoms — regulating cycles, reducing androgen exposure, protecting the endometrium — but it does not address the underlying insulin resistance that drives most PCOS. When the pill is stopped, symptoms typically return. Long-term management of insulin resistance through lifestyle, metformin, or inositols addresses the root cause in a way that symptom management alone does not.